Extended indication Treat pseudomonas aeruginosa infections in non–cystic fibrosis bronchiectasis
Therapeutic value Possible added value
Registration phase Clinical trials

Product

Registration

Therapeutic value

Expected patient volume per year

Expected cost per patient per year

Potential total cost per year

Off label use

Indication extension

Other information